Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 300,000 shares at $13.93 ($4.2M) on 2022-08-18, disclosed to the SEC on 2022-08-19.
Open-market sale of $4.2M CPRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.93 | 25,000 | $348K | 8.3% |
| 2 | $13.93 | 50,000 | $697K | 16.6% |
| 3 | $13.95 | 50,000 | $698K | 16.6% |
| 4 | $13.96 | 50,000 | $698K | 16.6% |
| 5 | $14.10 | 125,000 | $1.8M | 41.9% |
| Total | $14.01 avg | 300,000 |
| $4.2M |
| 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |